Meeting Agenda (Wednesday, July 17, 2019 @ 10:00 am ET)
Agenda:
- Progress report
Please join via Skype: https://meet.lilly.com/abedtash_hamed/53B8L6JC
Meeting Agenda (Wednesday, July 31, 2019 @ 10:00 am ET)
Agenda:
- Progress report by @trinklek et al.
- Plan for initial release
Please join via Skype: https://meet.lilly.com/abedtash_hamed/53B8L6JC
Meeting Minutes (July 31, 2019)
Attendees:
Hamed, Katy, Tiffany, Vincent, Keleon, Melanie, Qi
Notes:
- Katy’s team did an excellent job on listing differentiating factors between ATC classes having the same ingredient name.
- We reviewed and troubleshoot the challenges in the list for cardiovascular (C classes) and corticosteroids (multiple classes) classes look good and ready for implementation. Just waiting on precise ingredient name of corticosteroids.
Actions:
- Katy’s team will provide the precise ingredient name (generic + salt) of corticosteroids.
@Christian_Reich @aostropolets @trinklek
We are meeting this Wednesday to review what @trinklek’s team has put together in the past few weeks, and plan for the release, but I got a conflict with another meeting. Any chance to start with an hour delay at 11am ET? Please let me know if does not work well for you.
Thanks!
@abedtash_hamed I have a conflict with an all day seminar this week, but I confirmed with @callahantiff and the students that they can make it. @callahantiff may need to drop off half way through, but I think that is fine. I can have the team update me later.
@trinklek: Great! I’ll send the updated invite. I should also thank you and your team for the wonderful work you did on corticosteroids and cardiovascular classes. Well done!
Meeting Agenda (Wednesday, August 14, 2019 @ 11:00 am ET)
** NOTE: The meeting will start an hour late at 11am ET.
Agenda:
- Progress report
- Discuss release date
Please join via Skype: https://meet.lilly.com/abedtash_hamed/53B8L6JC
Meeting Minutes (August 14, 2019)
Attendees:
Hamed, Tiffany, Vincent, Keleon, Anna
Notes:
- Discussed the metadata Vincent and Keleon have provided.
- Anna needs the rules (logic) narration to implement the mapping.
- The target date to finish implementation: August 31
- The target date for initial release: September 8
Actions:
- Hamed will convert the metadata sheet to rules narration and will send over to Anna.
- Keleon and Vincent are willing to help further with N02 (Analgesics) mapping.
NO meeting tomorrow (September 25, 2019).
We are moving the biweekly meeting to Thursdays or Fridays starting October 2019.
If you are interested in joining the working group, please fill out the doodle survey below to pick the time that would work best for everyone:
I just added Thursdays to the poll. If you have submitted your time, please make sure to revisit the link below and add your time on Thursdays. Thanks so much!
cc: @callahantiff @Christian_Reich @aostropolets @anthonysena
Meeting Agenda (Thursday, October 3, 2019 @ 11:00 am ET)
Agenda:
- Progress report
- Next steps
Please join via Skype: https://meet.lilly.com/abedtash_hamed/53B8L6JC
Meeting Minutes (October 3, 2019)
Attendees:
Hamed, Anna, Qi
Notes:
- We are starting documenting the pipeline and the Cookbook. Anna is going to set up a Google Doc to start.
- Contortionists still need more clarification on differentiating factors between classes. Hamed will work on that.
Actions:
- Anna: Google Doc for documentation
- Hamed: Corticosteroids and Cardiovascular classes
- Hamed: Prepare template for documentation
Meeting Agenda (Thursday, October 17, 2019 @ 11:00 am ET)
- This will be a short call - about 30 minutes
Agenda:
- Progress report
- Next steps
Please join via Skype
Meeting Agenda (Thursday, November 14, 2019 @ 11:00 am ET)
Agenda:
- Discuss release of ATC mapping for beta testing. EHDEN team is waiting! @Christian_Reich, @aostropolets
Please join via Skype
Meeting Minutes (November 14, 2019)
Attendees:
Anna, Hamed
- A comprehensive relationship set will be provided for each ATC class to RxNorm. So, we will explicitly identify “valid” concepts in RxNorm that can be related to ATC classes. The user will not be allowed to extrapolate the relationships through concept ancestry.
- Regarding “ingredient” concepts: We will have 2 types of relationships between one ATC class and corresponding ingredient concepts: 1) “Mapped to Standard concept” indicating the ingredient concept is a standard concept for the ATC class because there is no differentiating factors involved. 2) “Contains ingredient” (something similar-not finalized yet, it may change later) indicating that the product under the ATC class has the corresponding ingredients. This relationship should not be used for ETL-ing the data.
- Regarding “indication”: We are not providing relationships to indications for now.
- Regarding “dose form”: We are not providing relationships to indications for now.
We are collecting time availability in 2020 to set up a new “monthly” meeting series. We will be mainly working on documenting the pipeline and user guides, and refining the mappings.
Please feel free to fill out this doodle below if you are interested to join:
https://doodle.com/poll/vzn2wmiv9x69tv3r
Thank you!
Hamed
We will resume ATC WG monthly meetings starting Thursday, Feb 27, 2020 @ 10am ET.
Please find more information about the working group, objectives, and the 2020 deliverables, here: https://www.ohdsi.org/web/wiki/doku.php?id=projects:workgroups:atc
Feel free to join and looking forward to having you on the team!
Thank you!
Hamed